anmelden
25 € WM-Startbonus auf dein Cash-Konto
BX Swiss TOP 30 CHF
1.480,29
PKT
-6,17
PKT
-0,42
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.04.12 | Holcim sell | Citigroup Corp. | |
| 05.04.12 | Roche outperform | Credit Suisse Group | |
| 05.04.12 | Nestlé overweight | HSBC | |
| 04.04.12 | UBS neutral | Credit Suisse Group | |
| 03.04.12 | Nestlé kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 03.04.12 | Givaudan neutral | Nomura | |
| 03.04.12 | Zurich Insurance neutral | Sarasin Research | |
| 03.04.12 | Lonza neutral | Sarasin Research | |
| 03.04.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 03.04.12 | Julius Bär equal-weight | Morgan Stanley | |
| 03.04.12 | UBS buy | Goldman Sachs Group Inc. | |
| 02.04.12 | UBS neutral | Nomura | |
| 02.04.12 | UBS buy | Nomura | |
| 02.04.12 | Novartis buy | Sarasin Research | |
| 30.03.12 | UBS underperform | Exane-BNP Paribas SA | |
| 30.03.12 | UBS underperform | Exane-BNP Paribas SA | |
| 30.03.12 | Roche neutral | WestLB AG | |
| 30.03.12 | Holcim neutral | HSBC | |
| 30.03.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 30.03.12 | Roche outperform | Exane-BNP Paribas SA | |
| 29.03.12 | Roche overweight | J.P. Morgan Cazenove | |
| 29.03.12 | Zurich Insurance neutral | Sarasin Research | |
| 29.03.12 | Swisscom neutral | Sarasin Research | |
| 29.03.12 | Holcim sell | ING | |
| 27.03.12 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
| 27.03.12 | Nestlé hold | ING | |
| 27.03.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 26.03.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 26.03.12 | Holcim neutral | Exane-BNP Paribas SA | |
| 26.03.12 | UBS overweight | Morgan Stanley | |
| 26.03.12 | Zurich Insurance kaufen | Die Actien-Börse | |
| 23.03.12 | Sika neutral | Sarasin Research | |
| 22.03.12 | Givaudan sell | Goldman Sachs Group Inc. | |
| 22.03.12 | Straumann neutral | Sarasin Research | |
| 21.03.12 | Novartis buy | Deutsche Bank AG | |
| 21.03.12 | Nestlé overweight | Morgan Stanley | |
| 21.03.12 | ABB (Asea Brown Boveri) outperform | Sanford C. Bernstein and Co., Inc. | |
| 20.03.12 | Nestlé hold | ING | |
| 20.03.12 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 20.03.12 | Nestlé outperform | Exane-BNP Paribas SA |